5871 - 5880 of 7915 Results
Title
Year
-
OPENTitle: Color discrimination errors associate with axial motor impairments in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 6Start Page: 864End Page: 869Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12527Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12527Citation Count: 6
-
OPENTitle: Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6357Start Page: 1255End Page: 1261Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aam9080Best OA location URL: https://science.sciencemag.org/content/sci/357/6357/1255.full.pdfCitation Count: 666
-
OPENTitle: Improved diagnosis of Parkinson's disease from a detailed olfactory phenotypeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 10Start Page: 714End Page: 721Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.447Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.447Citation Count: 14
-
OPENTitle: MitoNEET (CISD1) Knockout Mice Show Signs of Striatal Mitochondrial Dysfunction and a Parkinson’s Disease PhenotypeJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 8Issue #: 12Start Page: 2759End Page: 2765Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00287Best OA location URL: https://europepmc.org/articles/pmc5964979?pdf=renderCitation Count: 75
- Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRI2017OPENTitle: Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRIJournal Name: Nature ProtocolsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 10Start Page: 2050End Page: 2080Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nprot.2017.081Best OA location URL: https://europepmc.org/articles/pmc6185898?pdf=renderCitation Count: 129
-
OPENTitle: Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 288End Page: 297Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.09.002Best OA location URL: https://europepmc.org/articles/pmc6386531?pdf=renderCitation Count: 75
-
RESTRICTEDTitle: Alcohol improves cerebellar learning deficit in myoclonus–dystonia: A clinical and electrophysiological investigationJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 4Start Page: 543End Page: 553Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25035Citation Count: 41
- Engineered Axonal Tracts as “Living Electrodes” for Synaptic‐Based Modulation of Neural Circuitry2017OPENTitle: Engineered Axonal Tracts as “Living Electrodes” for Synaptic‐Based Modulation of Neural CircuitryJournal Name: Advanced Functional MaterialsPublisher: WileyVol: 28Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1002/adfm.201701183Best OA location URL: https://rss.onlinelibrary.wiley.com/doi/am-pdf/10.1002/adfm.201701183Citation Count: 44
-
RESTRICTEDTitle: Serum lipid alterations in GBA-associated Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 58End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.026Citation Count: 71
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7